Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-03-31

Clinical Trial Update: Pharmacokinetic Study of Polidocanol Endovenous Microfoam (PEM) [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of polidocanol endovenous microfoam (PEM) in varicose veins completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Polidocanol Endovenous Microfoam (PEM) (polidocanol endovenous microfoam)

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Varicose Veins | Phase 1 | Status: COMPLETED | Results posted: 2014-03-31